α-Glucosidase inhibitors as potential broad based anti-viral agents (Q29036682)

Europe PubMed Central

title

α-Glucosidase inhibitors as potential broad based anti-viral agents (English)

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

author name string

Anand Mehta

1

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

Nicole Zitzmann

2

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

Pauline M Rudd

3

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

Timothy M Block

4

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

Raymond A Dwek

5

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

language of work or name

English

0 references

publication date

23 June 1998

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

volume

430

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

issue

1-2

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

27 March 2017

page(s)

17-22

1 reference

https://doi.org/10.1016%2FS0014-5793%2898%2900525-0

How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Conformation-independent binding of monoglucosylated ribonuclease B to calnexin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Aminosugar derivatives as potential anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Inhibitors of protein glycosylation and glycoprotein processing in viral systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

The effects of inhibitors of glucosidase I on the formation of Sindbis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Glycosylation inhibitors in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Molecular genetics of pestiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

Recognition of the oligosaccharide and protein moieties of glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0

inferred from DOI database lookup

7 January 2021

based on heuristic

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900525-0